Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2876842 | 1.00 | KDM4E (0.35) | KDM4EHTTATMUSP30OPRM1 | |
| SCHEMBL2874208 | 0.90 | KDM4E (0.38) | KDM4EHTTATMUSP30OPRM1 | |
| SCHEMBL2879323 | 0.90 | KDM4E (0.38) | KDM4EHTTATMUSP30OPRM1 | |
| SCHEMBL2874240 | 0.90 | KDM4E (0.38) | KDM4EHTTATMUSP30OPRM1 | |
| SCHEMBL2877206 | 0.90 | KDM4E (0.38) | KDM4EHTTATMUSP30OPRM1 | |
| SCHEMBL3809138 | 0.88 | OPRM1 (0.38) | KDM4EHTTATMOPRM1 | |
| SCHEMBL2870891 | 0.87 | NR1I2 (0.38) | KDM4EHTTATM | |
| SCHEMBL2870824 | 0.87 | KDM4E (0.38) | KDM4EHTTATMUSP30OPRM1 | |
| SCHEMBL2870916 | 0.87 | NR1I2 (0.38) | KDM4EHTTATM | |
| SCHEMBL2879449 | 0.87 | KDM4E (0.36) | KDM4EHTTATMUSP30OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1569929-B9 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VIROCHEM PHARMA INC (CA) | 2011-09-14 | — | — | EP | claimed |
| EP-1569929-B1 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VIROCHEM PHARMA INC (CA) | 2010-05-05 | — | — | EP | claimed |